Evaluation of quality of life in patients with heart disease being treated with colchicine
Phase 2
Recruiting
- Conditions
- Patients with heart failure.Heart failure
- Registration Number
- IRCT20111206008307N38
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with heart failure
Patients with a history of cardiac ischemia
Patients with a history of thromboembolism
Patients with high serum levels of inflammatory factors in heart failure and cardiovascular problems
Patients with less renal glomerular filtration rate 30mm Hg /min/1.73 m2
Patients with symptomatic hypotension and systolic pressure below 100 or above 180 mm Hg
Complete the consent form
Exclusion Criteria
Patients with heart failure who are treated on an outpatient basis and do not need to be hospitalized
Patients with heart failure are in the age group under 18 years and over 80 years
Patients with heart failure with colchicine allergy
Patients with heart failure who have not completed the consent form
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the quality of life of heart failure patients with administration of the drug. Timepoint: Evaluation and determination of quality of life in patients with heart failure at the beginning of the study (before the intervention), 30 days and 90 days after the intervention. Method of measurement: Using the completion of the KCCQ questionnaire.
- Secondary Outcome Measures
Name Time Method